Bayer MRI contrast agent gadoquatrane meets goals in phase 3 trials
Bayer (OTCPK:BAYRY) said that phase 3 data on its experimental MRI contrast agent gadoquatrane met primary and secondary ...
Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary ...
Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies ...
GlobalData on MSN3 个月
GE HealthCare’s manganese-based MRI contrast agent shines in Phase I trial
GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance ...
Vaping — Even Without Nicotine — Has an Immediate Negative Effect on Lungs, Research Shows
Vaping affects the amount of oxygen being taken in by the lungs, regardless of whether it contained nicotine, according to a ...
mccormick.northwestern.edu9 年
BME 327: Magnetic Resonance Imaging
Students in the fields of engineering, biology, and neuroscience who are interested in aging in depth knowledge about Magnetic resonance imaging (MRI) which is a diagnostic imaging technique ... fast ...